Data

#Data #Diagnostics #Genetics / genomics #Healthcare #Public health #Rare disease #Whole genome sequencing

Personalising WGS doubles diagnosis of rare diseases 

A new study led by Medical Research Council-funded researchers from UCL has found that tailoring the analysis of whole genome sequencing to individual patients could double the diagnostic rates of rare diseases.  Context   In 2018, the UK’s department of health announced an NHS Genomic Medicine… Read More

#News

Genomics
#Biotechnology #Comment #Data #Gene editing #Genetics / genomics #Genome sequencing #Healthcare #Public health #Research #Whole genome sequencing

Why genomic healthcare data matters in the development of new therapies 

Genomic healthcare data is critical to identify disease risk, ancestry, traits and response to medicines and aids in the development of new targeted therapies – precision medicines. DDW’s Megan Thomas observes developments of accessibility in this sector and the potential impact.  The origins  One might… Read More

#Exclusive Content #Opinion #Trends & Analysis

#Antibodies #Biologics #Data #Drug design #Exscientia

Exscientia extends capabilities beyond small molecules 

Throughout 2022, Exscientia has progressed AI-driven capabilities for virtual biologics design, such as human antibodies, and is now establishing an automated biologics laboratory in Oxford to internally generate and profile novel antibodies.   Context  Current approaches to optimise antibodies, even those that use machine learning, still… Read More

#News

#Biotechnology #Data #Precision medicine #Webinar

Webinar offers an insider’s view on computational drug discovery  

Collaborative Drug Discovery (CDD) is hosting a webinar in which CDD’s Eric Gifford speaks with two industry experts, Dr Josh Horan and Dr Michael Kappler about their experience working with data at biotech companies.   The live webinar will take place on December 1, 2022 at 8AM (PT), 11AM… Read More

#News

Digital notebook
#Data #Data management #Data security #Electronic Lab Notebooks (ELN) #Laboratory data

Going paperless – the move to electronic lab notebooks 

Listen to this article on the DDW podcast: Barry Bunin, PhD, CEO of Collaborative Drug Discovery explores the rise of electronic lab notebooks and why researchers should be transitioning to digital methods of recording data.  The laboratory notebook has been around for centuries. Read More

#Exclusive Content

#Biotechnology #Data #Immunology / Virology & Vaccines #In Silico Biology

Sekkei Bio implements system to centralise research data 

Sekkei Bio, an India-based company dedicated to building technologies for drug and vaccine design with global impact, has implemented CDD Vault as the main platform to house its research data.   Sekkei Bio has made progress toward finding therapies for diabetes and pain, and has a management team… Read More

#News

#AI #Data #Drug discovery

BenevolentAI achieves third milestone with AstraZeneca

AstraZeneca has identified an additional target for its idiopathic pulmonary fibrosis (IPF) pipeline using an AI system designed by drug discovery company BenevolentAI. It is now the third target from that collaboration that has been identified using BenevolentAI’s platform. AstraZeneca is using the company’s Benevolent Platform across two disease areas… Read More

#News

#Animal models #Data #Genetics / genomics

Can animal genomics help find therapies for human disease?

Listen to this article on the DDW Podcast: Lu Rahman spoke to Ashley Zehnder, CEO of Fauna Bio, a biotech harnessing the power of comparative and functional animal genomics to find better therapies for human disease, including neurologic, metabolic, fibrotic and cardiovascular disorders. “Comparative genomics is the process of… Read More

#Exclusive Content

#Data #Laboratory data #Software

PerkinElmer highlights lab solutions at Bio-IT  

Life sciences company PerkinElmer is exhibiting at the Bio-IT World Conference and Expo this week ( 3-5 May) in Boston US.   The company is exhibiting a range of solutions that can help researchers in labs make well-informed, data-driven decision on therapeutic candidates by using cloud-based informatics… Read More

#News

#Data #EMA #Regulatory

What an EMA decision means for data-based regulatory submissions

The European Medicines Agency (EMA) has confirmed that the UNICOM’s DADI (Digital Application Dataset Integration) project will now serve as a ‘Plan B’ for the implementation of regulatory data submissions. Amplexor’s Renato Rjavec looks at the opportunities and challenges this presents for pharma companies. A more data-driven way of managing… Read More

#Exclusive Content #Opinion #Regulatory

#Analysis #Clinical trials #Data #Research #Ukraine

How war in Ukraine impacts global clinical development 

New global data analysis from Phesi shows the extent of the impact from the war in Ukraine on clinical development.   Phesi analysed pivotal trials sponsored by pharmaceutical companies that represent the most critical global clinical development activities.   The findings  The findings show that… Read More

#News #Trending News

Woman reaches for inhaler
#Asthma #Data #Research

40% of asthma patients overusing inhalers, says data 

New results from an observational data analysis of asthma inhaler therapy found that short-acting beta2-agonist (SABA) reliever overuse is a global issue adversely impacting asthma outcomes.1,2   Data from across the SABA Use IN Asthma (SABINA) global programme have been published in The Journal of Allergy… Read More

#News #Trending News

#Biomedical research #Data #Research

Spotlight: Tackling the issue of scientific data waste 

More than half of all scientific research is irreproducible, and more than 80% of scientific research data is being lost within 20 years. In the biomedical field alone, irreproducible research costs the industry £28 billion (US$38 billion) every year. Megan Thomas talks to Founder of Labstep Jake Schofield, about… Read More

#Business & Investment #Editor's Choice #Exclusive Content #Intelligence #News #Opinion #Start-up Zone #Trends & Analysis

#Data #Healthcare #Public health #Report #Study

Research reveals attitudes to Covid-19 treatment in the UK 

Pharmaceutical companies must keep improving Covid-19 treatments in line with new variants without sidelining work in other areas of health, according to new data from YouGov and Informa Pharma Intelligence, a provider for the biopharma industry.   The report  This data, included in Informa Pharma’s ‘Q4… Read More

#Covid-19 #News

#Clinical trials #Data #FDA #HIV

HIV prevention options expanded in the US 

The US Food and Drug Administration (FDA) has approved a long-acting HIV prevention medication for the first time.   The drug  Developed by ViiV Healthcare, the medicine is long-acting cabotegravir injected once every two months. The FDA has approved the medicine for use by adults and adolescents weighing… Read More

#News #Trending News

#Antibodies #Biotherapeutics #Covid-19 #Data #Funding #Immunology / Virology & Vaccines

Twist Bioscience spins out Covid antibodies into Revelar Biotherapeutics

Twist Bioscience has launched Revelar Biotherapeutics to develop and commercialise an antibody that neutralises all known variants of concern of the SARS-CoV-2 virus in preclinical studies.   In addition, Revelar will have the ability to leverage the antibody discovery and optimisation platform of Twist Biopharma to license additional antibodies for up to five targets over the next four… Read More

#Covid-19 #News